REDWX
Price
$18.99
Change
+$0.02 (+0.11%)
Updated
Nov 13 closing price
VSTSX
Price
$283.82
Change
-$0.19 (-0.07%)
Updated
Nov 13 closing price
Ad is loading...

REDWX vs VSTSX

Header iconREDWX vs VSTSX Comparison
Open Charts REDWX vs VSTSXBanner chart's image
Aspiration Redwood
Price$18.99
Change+$0.02 (+0.11%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$283.82
Change-$0.19 (-0.07%)
VolumeN/A
CapitalizationN/A
REDWX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REDWX vs. VSTSX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REDWX is a StrongBuy and VSTSX is a Buy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.73T vs. REDWX (152M). VSTSX pays higher dividends than REDWX: VSTSX (1.36) vs REDWX (0.41). REDWX was incepted earlier than VSTSX: REDWX (9 years) vs VSTSX (8 years). REDWX is a more actively managed with annual turnover of: 30.75 vs. VSTSX (2.00). REDWX has a lower initial minimum investment than VSTSX: REDWX (10) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 33.42 vs. REDWX (23.30). VSTSX return over 5 years is better than : 87.54 vs. REDWX (48.20).
REDWXVSTSXREDWX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD13.30524.91253%
Front LoadN/AN/A-
Min. Initial Investment1050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets152M1.73T0%
Annual Yield % from dividends0.411.3630%
Returns for 1 year23.3033.4270%
Returns for 3 years1.9622.889%
Returns for 5 years48.2087.5455%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALKT37.790.19
+0.51%
Alkami Technology
MTCH30.74-0.14
-0.45%
Match Group
PLOW25.36-0.12
-0.47%
Douglas Dynamics
INM0.23-0.02
-7.78%
InMed Pharmaceuticals
BCAB1.99-0.20
-9.13%
BioAtla